- Home
- BZH vs GHRS Comparison
BZH vs GHRS Comparison
Compare BZH & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- GHRS
- Stock Information
- Founded
- BZH 1985
- GHRS 2018
- Country
- BZH United States
- GHRS Ireland
- Employees
- BZH N/A
- GHRS N/A
- Industry
- BZH Homebuilding
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- BZH Consumer Discretionary
- GHRS Health Care
- Exchange
- BZH Nasdaq
- GHRS Nasdaq
- Market Cap
- BZH 666.1M
- GHRS 737.5M
- IPO Year
- BZH 1994
- GHRS 2021
- Fundamental
- Price
- BZH $23.58
- GHRS $14.76
- Analyst Decision
- BZH Strong Buy
- GHRS Strong Buy
- Analyst Count
- BZH 3
- GHRS 8
- Target Price
- BZH $33.00
- GHRS $30.63
- AVG Volume (30 Days)
- BZH 320.1K
- GHRS 204.8K
- Earning Date
- BZH 07-31-2025
- GHRS 05-08-2025
- Dividend Yield
- BZH N/A
- GHRS N/A
- EPS Growth
- BZH N/A
- GHRS N/A
- EPS
- BZH 3.10
- GHRS N/A
- Revenue
- BZH $2,436,131,000.00
- GHRS N/A
- Revenue This Year
- BZH N/A
- GHRS N/A
- Revenue Next Year
- BZH $14.27
- GHRS N/A
- P/E Ratio
- BZH $7.60
- GHRS N/A
- Revenue Growth
- BZH 13.50
- GHRS N/A
- 52 Week Low
- BZH $17.37
- GHRS $6.00
- 52 Week High
- BZH $38.22
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- BZH 63.10
- GHRS 66.16
- Support Level
- BZH $21.88
- GHRS $11.82
- Resistance Level
- BZH $24.30
- GHRS $12.94
- Average True Range (ATR)
- BZH 0.83
- GHRS 0.99
- MACD
- BZH 0.17
- GHRS 0.19
- Stochastic Oscillator
- BZH 79.87
- GHRS 84.53
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.